Quidel | QDEL - Sales Revenues


Quidel reported $724M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Agilent USD 1.8B 63M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Danaher USD 5.95B 890M Mar/2026
Haemonetics USD 338.97M 11.97M Dec/2025
Illumina USD 1.16B 80M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Myriad Genetics USD 209.8M 4.1M Dec/2025
Neogen USD 211.2M 13.49M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quidel USD 724M 24M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
STAAR Surgical USD 239.4M 144.7M Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Waters USD 932M 132M Dec/2025